0001127602-20-018491.txt : 20200602
0001127602-20-018491.hdr.sgml : 20200602
20200602171252
ACCESSION NUMBER: 0001127602-20-018491
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200529
FILED AS OF DATE: 20200602
DATE AS OF CHANGE: 20200602
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rothman Paul
CENTRAL INDEX KEY: 0001601332
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-06571
FILM NUMBER: 20938013
MAIL ADDRESS:
STREET 1: 6 MEADOW ROAD
CITY: BALTIMORE
STATE: MD
ZIP: 21212
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Merck & Co., Inc.
CENTRAL INDEX KEY: 0000310158
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 221918501
STATE OF INCORPORATION: NJ
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
BUSINESS PHONE: 908-740-4000
MAIL ADDRESS:
STREET 1: 2000 GALLOPING HILL ROAD
CITY: KENILWORTH
STATE: NJ
ZIP: 07033
FORMER COMPANY:
FORMER CONFORMED NAME: Merck & Co. Inc.
DATE OF NAME CHANGE: 20091103
FORMER COMPANY:
FORMER CONFORMED NAME: SCHERING PLOUGH CORP
DATE OF NAME CHANGE: 19920703
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2020-05-29
0000310158
Merck & Co., Inc.
MRK
0001601332
Rothman Paul
JOHNS HOPKINS MEDICINE
733 N. BROADWAY, SUITE 100
BALTIMORE
MD
21205-2196
1
Common Stock
100
D
Phantom Stock
2020-05-29
4
A
0
2477.7007
80.72
A
Common Stock
2477.7007
16361.5907
D
1-for-1
Phantom stock units are to be settled 100% in cash upon reporting person's termination of service in accordance with a distribution schedule elected pursuant to the terms of the Plan for Deferred Payment of Directors' Compensation.
Holdings include shares acquired in dividend reinvestment transactions.
Faye C. Brown as Attorney-in-Fact for Paul B. Rothman
2020-06-02